ClinicalTrials.gg

Aralez Pharmaceuticals clinical trials

The registry lists 27 studies whose lead sponsor is Aralez Pharmaceuticals or one of 1 company grouped under it. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Feb 18, 2016.

Our grouping of 1 registry name, not the registry’s. See them and correct one ↓

What it is testing

The drugs Aralez Pharmaceuticals’ studies test, most studies first; none is open now — 9 drugs with a page of their own. Each count opens the studies in search.

Studies, none open

All 27 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Completed2696%
  • Stopped early14%

Phase

  • Phase 313
  • Phase 112
  • Phase 22

Where

  • United States24
  • Canada2

Over the years

  1. 07
  2. 1008
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 026

By the year each study started; 7 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Aralez Pharmaceuticals.

  • POZEN
    Acquired — became part of Aralez Pharmaceuticals, Feb 5, 2016 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    27 studies →

Studies

Recruiting first, then most recently updated. Showing 27 of 27.